Form D · Other Technology
Rebound Therapeutics Corp
Irvine, CA · CIK 0001662622
Offering snapshot reported Jul 28, 2017 · SEC filing
- Reported sold
- $16.5M Offering amount: $16.5M
- Investors reported
- 49 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Jul 14, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 28, 2017 | Initial | $16,499,999 | No comparison | 49 | SEC filing |
| Dec 31, 2015 | Initial | $3,760,000 | No comparison | 29 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-291665
Series B Preferred Stock
Source: Form D, filed Jul 28, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael R. Henson | Director, Executive |
| Tracy Pearson | Executive |
| Jeffrey J. Valko | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
13844 Alton Parkway, Suite 131
Irvine, CA, 92618
Irvine, CA, 92618